1. Medtech Insight
  2. >>Device Area
  3. >>Cardiology

Start-Up Spotlight: CorWave Takes Inspiration From Nature To Tackle Heart Failure

 
• By Barnaby Pickering

Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.

Start-up Spotlight

CorWave SA hopes to advance the treatment of end-stage heart failure with a left ventricular assist device (LVAD) that creates a pulse with a mechanism inspired by the motion of a fish’s tail.

Since its formation in 2012 by MD Start, CorWave has aimed to improve the prognosis for patients suffering from heart failure, a degenerative loss of contractility of the heart, which

CorWave SA
  • Address: CorWave 17 rue de Neuilly 92110 Clichy France
  • Contact: Kevin Noblet
  • Founded: 2012 through the MDstart Hub
  • Founders: Gérard Hascoët
  • Number of Employees: Almost 50

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cardiology

Digital Health And AI Tools Advance Cardiac Event Prediction, SCAI 2025 Data Show

 
• By Shubham Singh

Out-of-hospital cardiac arrest remains one of the most challenging and resource-intensive emergencies in cardiovascular care. At SCAI 2025, clinicians presented a novel algorithm that improved triage decisions and reduced unnecessary interventions.

Thousands Of Cardiac Digital Twins Reveal Novel Connections With Mental Health

 
• By Natasha Barrow

King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.

SS Innovations Files For De Novo For SSi Mantra 3 Surgical Robotic System For Multispecialty Indications

 
• By Marion Webb

SS Innovations announced plans to file a de novo application with the US FDA for its SSi Mantra 3 surgical robot, already approved for marketing in six countries. The Florida-based firm also plans to pursue the CE mark for European commercialization.

More from Device Area